Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Yiska Weisblum
Affiliation
Rockefeller University
ORCID
Career Start Year
2011
Papers
48
H Index
30
Expertise
CM4AI Collaborator
Andrej Sali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
35229640
VPS29 Exerts Opposing Effects on Endocytic Viral Entry.
mBio
2022
35818364
Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection.
Open Forum Infect Dis
2022
35915556
Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection.
Gut Microbes
2022
35030645
Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
N Engl J Med
2022
35294338
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry.
Elife
2022
33173867
Evolution of Antibody Immunity to SARS-CoV-2.
bioRxiv
2021
33851164
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2.
bioRxiv
2021
33567448
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
Nature
2021
33821268
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry.
bioRxiv
2021
33758864
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies.
bioRxiv
2021
33758856
Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies.
bioRxiv
2021
33501451
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
bioRxiv
2021
34874007
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape.
Elife
2021
34931199
Plasma neutralization properties of the SARS-CoV-2 Omicron variant.
medRxiv
2021
34648371
Replication and single-cycle delivery of SARS-CoV-2 replicons.
Science
2021
34544114
High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape.
Nature
2021
34015271
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.
Cell
2021
34234131
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.
Nat Commun
2021
34331873
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.
Immunity
2021
33461210
Evolution of antibody immunity to SARS-CoV-2.
Nature
2021
33270134
Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection.
Clin Infect Dis
2021
32511384
Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals.
bioRxiv
2020
33112236
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
Elife
2020
33052353
Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection.
medRxiv
2020
32692348
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.
J Exp Med
2020
32917729
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients.
J Clin Microbiol
2020
32577675
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients.
medRxiv
2020
32577658
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.
bioRxiv
2020
32577645
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies.
bioRxiv
2020
32743579
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
bioRxiv
2020
32645326
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.
Cell
2020
32727881
Human Nasal Turbinate Tissues in Organ Culture as a Model for Human Cytomegalovirus Infection at the Mucosal Entry Site.
J Virol
2020
32843346
A mutation in POLR3E impairs antiviral immune response and RNA polymerase III.
Proc Natl Acad Sci U S A
2020
32555388
Convergent antibody responses to SARS-CoV-2 in convalescent individuals.
Nature
2020
31662489
Correction for Weisblum et al., "Zika Virus Infects Early- and Midgestation Human Maternal Decidual Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal Interface".
J Virol
2019
29712656
The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.
Antimicrob Agents Chemother
2018
27974560
Zika Virus Infects Early- and Midgestation Human Maternal Decidual Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal Interface.
J Virol
2017
28956761
APOBEC3A Is Upregulated by Human Cytomegalovirus (HCMV) in the Maternal-Fetal Interface, Acting as an Innate Anti-HCMV Effector.
J Virol
2017
28878071
Zika Virus Escapes NK Cell Detection by Upregulating Major Histocompatibility Complex Class I Molecules.
J Virol
2017
27160907
HCMV vCXCL1 Binds Several Chemokine Receptors and Preferentially Attracts Neutrophils over NK Cells by Interacting with CXCR2.
Cell Rep
2016
27760325
HSV1 MicroRNA Modulation of GPI Anchoring and Downstream Immune Evasion.
Cell Rep
2016
27264178
CEACAM1-Mediated Inhibition of Virus Production.
Cell Rep
2016
25683719
Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICAâ¿¿008 to Escape Elimination by NK Cells.
Cell Rep
2015
26318261
Human cytomegalovirus induces a distinct innate immune response in the maternal-fetal interface.
Virology
2015
26292329
Transition toward Human Cytomegalovirus Susceptibility in Early Human Embryonic Stem Cell-Derived Neural Precursors.
J Virol
2015
24586166
MicroRNA editing facilitates immune elimination of HCMV infected cells.
PLoS Pathog
2014
25291972
Models of vertical cytomegalovirus (CMV) transmission and pathogenesis.
Semin Immunopathol
2014
21976654
Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture.
J Virol
2011
1 - 48 of 48
Column Actions
Search
Recommended Authors
Sebastian Weigang
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Career Start Year
2018
Number of shared co-authors
3
James Logue
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year
2017
Number of shared co-authors
3
Mir M Khalid
Gladstone Institutes
Career Start Year
2016
Number of shared co-authors
1
Carolina Lucas
Yale School of Medicine
Career Start Year
2014
Number of shared co-authors
0
Laura A VanBlargan
Washington University School of Medicine
Career Start Year
2013
Number of shared co-authors
0
Hongjie Xia
University of Texas Medical Branch
Career Start Year
2012
Number of shared co-authors
0
Wilfredo F Garcia-Beltran
Ragon Institute of MGH
Career Start Year
2012
Number of shared co-authors
1
Craig B Wilen
Yale School of Medicine
Career Start Year
2010
Number of shared co-authors
1
Xuping Xie
University of Texas Medical Branch
Career Start Year
2010
Number of shared co-authors
1
Judd F Hultquist
Northwestern University Feinberg School of Medicine
Career Start Year
2008
Number of shared co-authors
1
Vineet D Menachery
University of Texas Medical Branch
Career Start Year
2008
Number of shared co-authors
1
Melissa M Coughlin
Centers for Disease Control and Prevention
Career Start Year
2006
Number of shared co-authors
0
Pavlo Gilchuk
Vanderbilt University Medical Center
Career Start Year
2005
Number of shared co-authors
0
Pavitra Roychoudhury
Fred Hutchinson Cancer Center
Career Start Year
2004
Number of shared co-authors
0
Natalie J Thornburg
Centers for Disease Control and Prevention (CDC)
Career Start Year
2003
Number of shared co-authors
1
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Career Start Year
2003
Number of shared co-authors
5
Lingshu Wang
National Institute of Allergy and Infectious Disease, National Institute of Health
Career Start Year
2003
Number of shared co-authors
0
Kayvon Modjarrad
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year
2002
Number of shared co-authors
3
Nuria Izquierdo-Useros
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year
2002
Number of shared co-authors
0
Robert H Carnahan
Vanderbilt University Medical Center
Career Start Year
1997
Number of shared co-authors
0
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year
1997
Number of shared co-authors
8
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year
1993
Number of shared co-authors
0
Lucy Thorne
University College London
Career Start Year
1992
Number of shared co-authors
0
Keith R Jerome
Fred Hutchinson Cancer Center
Career Start Year
1991
Number of shared co-authors
0
Rafael Delgado
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year
1988
Number of shared co-authors
0
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year
1987
Number of shared co-authors
2
Bart L Haagmans
Erasmus Medical Center
Career Start Year
1986
Number of shared co-authors
0
Michael S Diamond
Washington University School of Medicine
Career Start Year
1982
Number of shared co-authors
4
Ralph S Baric
University of North Carolina
Career Start Year
1981
Number of shared co-authors
5
James E Crowe
Vanderbilt University Medical Center
Career Start Year
1975
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Paul D Bieniasz
The Rockefeller University
Co-authored papers
30
Theodora Hatziioannou
The Rockefeller University
Co-authored papers
27
Fabian Schmidt
The Rockefeller University
Co-authored papers
26
Pamela J Bjorkman
Co-authored papers
13
Thiago Y Oliveira
The Rockefeller University
Co-authored papers
8
Charles M Rice
Rockefeller University
Co-authored papers
7
Hans-Heinrich Hoffmann
The Rockefeller University
Co-authored papers
7
Ronit Haimov-Kochman
Hadassah Hebrew University Medical Center
Co-authored papers
6
Michael P Rout
The Rockefeller University
Co-authored papers
3
David Noah Sather
Center for Global Infectious Disease Research, Seattle Children's Hospital
Co-authored papers
2
Celia A Schiffer
University of Massachusetts Chan Medical School
Co-authored papers
2
Paul Olivier
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Co-authored papers
2
Sarah Keegan
Institute for Systems Genetics, New York University Langone Medical Center
Co-authored papers
2
John D Aitchison
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Co-authored papers
2
Paul Dominic B Olinares
The Rockefeller University
Co-authored papers
2
Lucille M Rich
Center for Immunity and Immunotherapies, Seattle Children's Research Institute
Co-authored papers
2
David Feny??
Institute for Systems Genetics, NYU Grossman School of Medicine
Co-authored papers
2
Vladimir Vigdorovich
Center for Global Infectious Disease Research, Seattle Children's Hospital
Co-authored papers
2
Jason S Debley
Seattle Children's Hospital, University of Washington
Co-authored papers
2
Tanmoy Sanyal
University of California san francisco
Co-authored papers
2
Peter C Fridy
The Rockefeller University
Co-authored papers
2
Kelly R Molloy
The Rockefeller University
Co-authored papers
2
Brian T Chait
The Rockefeller University
Co-authored papers
2
Erica Y Jacobs
The Rockefeller University, St John's University
Co-authored papers
2
Lewis C Cantley
Co-authored papers
2
Robert A Colbert
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Co-authored papers
2
Junjie Wang
The Rockefeller University
Co-authored papers
2
Fred D Mast
Center for Global Infectious Disease Research, Seattle Children's Research Institute
Co-authored papers
2
Natalia E Ketaren
The Rockefeller University
Co-authored papers
2
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers
2
1 - 30